Specialists & Providers
Diagnostic Biomarkers
Treatments & Interventions
Prednisolone acetate
substance
Prednisolone sodium phosphate
substance
Prednisolone tertiary butylacetate
substance
Interferon alfacon-1
substance
Argatroban
substance
Prednisolone
substance
Desmopressin
substance
Desmopressin acetate
substance
Danaparoid
substance
Interferon gamma-1b
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Danaparoid sodium
substance
Lepirudin
substance
Peginterferon alfa-2b
substance
Peginterferon alfa-2a
substance
Avatrombopag
substance
Fostamatinib
substance
Lusutrombopag
substance
Avatrombopag maleate
substance
Clinical Trials
Recent Trials
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
Research Evidence
Peer-reviewed studies linked via MeSH term "Thrombocytopenia" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 302215000
- UMLS CUI
- C0040034
- Fully Specified Name
- Thrombocytopenic disorder (disorder)
- Specialists
- 2
- Diagnostic Biomarkers
- 3
- Known Treatments
- 20
- Clinical Trials
- 14
Related Health Goals
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.